联影医疗
(688271)
| 流通市值：1134.78亿 | | | 总市值：1134.78亿 |
| 流通股本：8.24亿 | | | 总股本：8.24亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 8,858,916,392.73 | 6,015,901,402.16 | 2,477,948,927.49 | 10,300,104,386.97 |
| 营业收入 | 8,858,916,392.73 | 6,015,901,402.16 | 2,477,948,927.49 | 10,300,104,386.97 |
| 二、营业总成本 | 7,918,571,581.46 | 5,075,101,040.91 | 2,132,796,705.76 | 9,385,271,546.62 |
| 营业成本 | 4,693,777,044.5 | 3,132,664,301.76 | 1,240,455,707.69 | 5,300,161,724.44 |
| 税金及附加 | 48,407,236 | 30,107,015.65 | 14,479,376.59 | 56,781,176.03 |
| 销售费用 | 1,522,649,084.89 | 938,304,878.27 | 384,106,190.53 | 1,823,187,055.28 |
| 管理费用 | 447,264,729.43 | 257,182,484.27 | 131,820,633.48 | 555,965,099.19 |
| 研发费用 | 1,250,296,831.18 | 766,458,924.01 | 378,872,051.95 | 1,761,466,670.35 |
| 财务费用 | -43,823,344.54 | -49,616,563.05 | -16,937,254.48 | -112,290,178.67 |
| 其中:利息费用 | 12,749,994.04 | 5,292,016.92 | 3,378,239.1 | 9,073,217.24 |
| 其中:利息收入 | -64,558,314.78 | -44,496,516.79 | -20,764,111.74 | -116,273,030.76 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -41,816,402.32 | -45,441,421.76 | -38,695,784.91 | 37,000,082.01 |
| 加:投资收益 | 60,684,708.13 | 39,841,032.04 | 14,529,364.7 | 98,073,989.14 |
| 资产处置收益 | -641,241.48 | -640,729.77 | - | -869,838.94 |
| 资产减值损失(新) | 480,051.63 | -197,713.08 | -52,668.06 | 13,842,775.25 |
| 信用减值损失(新) | -96,889,157.34 | -72,911,342.79 | -37,982,156.67 | -140,717,437.52 |
| 其他收益 | 318,963,467.13 | 215,480,112.85 | 115,812,587.45 | 444,193,498.96 |
| 四、营业利润 | 1,181,126,237.02 | 1,076,930,298.74 | 398,763,564.24 | 1,366,355,909.25 |
| 加:营业外收入 | 4,587,989.54 | 2,148,497.13 | 591,460.54 | 5,546,317.51 |
| 减:营业外支出 | 7,161,500.29 | 6,106,665.13 | 1,536,564.68 | 20,194,712.78 |
| 五、利润总额 | 1,178,552,726.27 | 1,072,972,130.74 | 397,818,460.1 | 1,351,707,513.98 |
| 减:所得税费用 | 76,246,522.85 | 85,076,398.44 | 32,293,254.84 | 109,783,513.52 |
| 六、净利润 | 1,102,306,203.42 | 987,895,732.3 | 365,525,205.26 | 1,241,924,000.46 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 1,102,306,203.42 | 987,895,732.3 | 365,525,205.26 | 1,241,924,000.46 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 1,120,234,330 | 998,018,064.12 | 370,082,216.76 | 1,261,869,451.27 |
| 少数股东损益 | -17,928,126.58 | -10,122,331.82 | -4,557,011.5 | -19,945,450.81 |
| 扣除非经常损益后的净利润 | 1,053,226,533.66 | 965,612,481.04 | 378,502,314.92 | 1,010,323,448.82 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.36 | 1.21 | 0.45 | 1.54 |
| (二)稀释每股收益 | 1.36 | 1.21 | 0.45 | 1.54 |
| 八、其他综合收益 | -15,265,169.31 | -3,315,448.42 | -2,289,461.42 | 6,068,286.44 |
| 归属于母公司股东的其他综合收益 | -15,265,169.31 | -3,315,448.42 | -2,289,461.42 | 6,068,286.44 |
| 九、综合收益总额 | 1,087,041,034.11 | 984,580,283.88 | 363,235,743.84 | 1,247,992,286.9 |
| 归属于母公司股东的综合收益总额 | 1,104,969,160.69 | 994,702,615.7 | 367,792,755.34 | 1,267,937,737.71 |
| 归属于少数股东的综合收益总额 | -17,928,126.58 | -10,122,331.82 | -4,557,011.5 | -19,945,450.81 |
| 公告日期 | 2025-10-30 | 2025-08-30 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |